Status:
COMPLETED
Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study
Lead Sponsor:
Carevive Systems, Inc.
Conditions:
CLL
Eligibility:
All Genders
18+ years
Brief Summary
This multi-site study will enroll approximately 100 CLL patients across 5 cancer institutions. The aim of the project is to ensure hematology care teams that are participating in new value-based reimb...
Detailed Description
Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in Western countries with 18,960 new cases and 4660 deaths expected in 2016. Rapid therapeutic advances in the past five ye...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All participants must be 18 years of age or older.
- Patient participants must have a diagnosis of CLL, and either be on active treatment or need first-line treatment.
- Patient participants must be able to access a web-based portal.
- All participants must be able to understand English.
- Exclusion Criteria
- Any patient who cannot understand written or spoken English.
- Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C, and D).
- The inclusion and exclusion criteria above will be used to screen for eligibility of all patients.
Exclusion
Key Trial Info
Start Date :
July 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2019
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT03231579
Start Date
July 21 2017
End Date
March 31 2019
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moffitt Cancer Institute
Tampa, Florida, United States, 33612